NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-152-2020-0-US-01 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST CD20 US 63/043,520 Abandoned
NCATS E-757-2013-2-US-07 4-((2-HYDROXY-3-METHOXYBENZYL)AMINO) BENZENESULFONAMIDE DERIVATIVES AS 12-LIPOXYGENASE INHIBITORS US DIV 16/909,712 11274077 Issued PDF
NIAID E-188-2015-0-US-05 POLYMER ADJUVANT US CON 16/907,912 Pending
NEI E-284-2012-2-US-09 METHODS AND COMPOSITIONS FOR TREATING GENETICALLY LINKED DISEASES OF THE EYE US National Stage 16/956,976 Abandoned
NCATS E-136-2020-0-US-01 METHOTREXATE ANALOGS AND METHODS OF USE US 63/042,262 Abandoned
NCI E-021-2015-0-US-31 ANTI-CD70 CHIMERIC ANTIGEN RECEPTORS US DIV 16/906,061 11999796 Issued PDF
NIAID E-130-2020-0-US-01 HUMAN IGA MONOCLONAL ANTIBODY THAT TARGETS A CONSERVED SITE ON THE PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN US 63/041,439 Abandoned
NEI E-070-2019-0-EP-05 INTERLEUKIN-27 PRODUCING B-CELL POPULATION AND USES THEREOF EP National Stage 20736554.5 Pending
NEI E-070-2019-0-JP-06 INTERLEUKIN-27 PRODUCING B-CELL POPULATION AND USES THEREOF JP National Stage 2021-575486 Pending
NEI E-070-2019-0-AU-03 INTERLEUKIN-27 PRODUCING B-CELL POPULATION AND USES THEREOF AU National Stage 2020295470 Pending
NEI E-070-2019-0-CA-04 INTERLEUKIN-27 PRODUCING B-CELL POPULATION AND USES THEREOF CA National Stage 3143998 Pending
NCI E-224-2020-0-US-01 Ex-miRNAs As Nerve Injury And Neuropathic Pain Biomarkers US 63/040,964 Abandoned
NEI E-070-2019-0-PCT-02 INTERLEUKIN-27 PRODUCING B-CELL POPULATION AND USES THEREOF PCT PCT PCT/US20/38368 Expired
NINDS E-088-2018-1-US-13 ANTI-HERV-K ENVELOPE PROTEIN ANTIBODIES AND METHODS FOR DETECTING HERV-K ENVELOPE PROTEIN IN PATIENTS WITH SPORADIC AMYOTROPHIC LATERAL SCLEROSIS US CON 16/903,947 10981977 Issued PDF
NHLBI E-064-2018-0-US-05 Inner Curvature Charge Concentration Device For Tissue Laceration US National Stage 16/954,710 Pending
NIDCR E-093-2019-0-US-01 SALIVA COLLECTION DEVICE AND METHOD OF USING THE SAME US 63/040,078 Abandoned
NCI E-188-2017-1-US-02 PEPTIDE HYDROGELS AND USE THEREOF US National Stage 16/954,492 11661439 Issued PDF
NIAID E-007-2015-0-US-35 CD47-targeted Therapies For The Treatment Of Infectious Disease US CON 16/902,068 1123-06-07 Issued PDF
NCI E-171-2018-8-US-06 MODIFIED CELLS AND METHODS OF THERAPY US CON 16/900,368 11925664 Issued PDF
NCI E-025-2015-0-US-04 ANTI-CD133 MONOCLONAL ANTIBODIES AND RELATED COMPOSITIONS AND METHODS US DIV 16/900,596 11352435 Issued PDF
NCI E-171-2018-8-US-07 MODIFIED CELLS AND METHODS OF THERAPY US CON 16/900,372 11266692 Issued PDF
NCI E-171-2018-8-US-05 MODIFIED CELLS AND METHODS OF THERAPY US CON 16/900,363 Abandoned
NIBIB E-144-2020-0-US-01 LIPOSOMAL VESICLES, METHODS OF MAKING, AND USES THEREOF US 63/038,380 Abandoned
NCATS E-229-2020-0-CO-01 Methods Of Combination Therapy For Treatment Of Mucopolysaccharidosis Type IVA Using Human Recombinant Nacetylgalactosamine
6-sulfatase (hrGALNS) And Pharmacological Chaperones 		CO ORD NC2020/0007242 Pending
NICHD E-141-2019-0-US-01 MONOMERIC AND OLIGOMERIC COMPOUND EMBODIMENTS AS CONTRACEPTIVES AND THERAPIES AND METHODS OF MAKING AND USING THE SAME US 63/037,952 Abandoned
NCI E-021-2015-0-AU-32 Anti-CD70 Chimeric Antigen Receptors AU DIV 2020203836 Issued
NCI E-078-2020-0-US-01 SIZE-DEPENDENT BRAIN AND LYMPHATIC DISTRIBUTION OF MACROMOLECULAR DRUG DELIVERY PLATFORM US 63/037,058 Abandoned
NIAID E-116-2020-1-US-01 SARS-COV ANTIBODIES AND THEIR USE US 63/037,323 Abandoned
NIBIB E-005-2012-3-US-12 MULTI-FOCAL STRUCTURED ILLUMINATION MICROSCOPY SYSTEMS AND METHODS US DIV 16/897,525 Abandoned
NIAID E-131-2020-3-US-01 Anti-Coronavirus Antibodies And Methods Of Use US 63/036,089 Abandoned
NCI E-085-2013-0-US-25 METHODS OF PRODUCING ENRICHED POPULATIONS OF TUMOR REACTIVE T CELLS FROM PERIPHERAL BLOOD US DIV 16/893,972 11679128 Issued PDF
NIAID E-143-2018-0-US-01 New Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines Bearing Deletion Of The NS1 Gene US 63/035,617 Abandoned
NICHD E-039-2016-1-AU-07 Treatment of Hormonal Disorders of Growth AU DIV 2020203709 Issued
NCI E-167-2017-0-KR-08 NOVEL CANCER TREATMENT UTILIZING PRE-EXISTING MICROBIAL IMMUNITY KR National Stage 10-2020-7016052 Pending
NIDCR E-485-2013-1-EP-03 COMPOSITIONS AND METHODS FOR THE INHIBITION OF PRURITUS EP National Stage 18804851.6 Issued
NIDCR E-485-2013-1-DE-05 COMPOSITIONS AND METHODS FOR THE INHIBITION OF PRURITUS DE EP 18804851.6 Issued
NIDCR E-485-2013-1-FR-06 COMPOSITIONS AND METHODS FOR THE INHIBITION OF PRURITUS FR EP 18804851.6 Issued
NIDCR E-485-2013-1-GB-07 COMPOSITIONS AND METHODS FOR THE INHIBITION OF PRURITUS GB EP 18804851.6 Issued
NCI E-239-2017-0-JP-12 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS JP National Stage 2020-530325 Issued
NCI E-239-2017-0-US-17 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS US National Stage 16/769,144 11466071 Issued PDF
NCI E-238-2017-0-US-03 METHODS OF ENRICHING CELL POPULATIONS FOR CANCER-SPECIFIC T CELLS USING IN VITRO STIMULATION OF MEMORY T CELLS US National Stage 16/768,930 Pending
NCI E-174-2018-2-US-13 CAS9 Modified TILS For Treatment Of Gastrointestinal Cancer US DIV 16/889,914 Abandoned
NIA E-061-2019-1-US-01 INHIBITORS OF LRP1-DKK PROTEIN COMPLEX TO PROMOTE CLEARANCE OF AMYLOID-BETA US 63/033,579 Abandoned
NCATS E-169-2019-0-US-01 DIFFERENTATION OF TROPHECTODERM LINEAGE CELLS FROM PLURIPOTENT STEM CELLS US 63/033,536 Abandoned
NINR E-223-2018-1-US-02 Rapid Nucleic Acids Preparation/Sample Preparation Via Hollow Centere Silica Microsphere US National Stage 16/768,802 11746372 Issued PDF
NCI E-121-2020-1-US-01 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST LMP2 US 63/032,954 Abandoned
NEI E-247-2020-0-US-01 BILAYER OF RETINAL PIGMENTED EPITHELIUM AND PHOTORECEPTOR PRECURSORS US 63/032,346 Abandoned
NCI E-174-2018-2-US-11 CAS9 Modified TILS For Treatment Of Gastrointestinal Cancer US CON 16/885,874 11154574 Issued PDF
NCI E-174-2018-2-US-12 CAS9 Modified TILS For Treatment Of Gastrointestinal Cancer US CON 16/885,882 Abandoned
NIAID E-131-2020-2-US-01 Anti-Coronavirus Antibodies And Methods Of Use US 63/030,530 Abandoned